CYTK (Cytokinetics Inc) Net earnings per share (EPS TTM)

Cytokinetics Inc (CYTK) - corporate logo

Growing demand for cardiovascular drugs is expanding the client base of Cytokinetics (CYTK), as evidenced by the annual EPS TTM trend. The value 4.20 serves as the current parameter value. AI implementation is accelerating drug synthesis, although testing remains manual. Meanwhile, stringent FDA oversight and costly R&D create significant barriers to entry for new players in this niche.

Cytokinetics Inc - CYTK Earnings per share for the last twelve months (period 02/11/2024 - 11/14/2026)

CYTK (Cytokinetics Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Market Price Cytokinetics Inc|CYTK - Consensus Target
- business market valuation indicators:
Market Capitalization Cytokinetics Corp|CYTK - Total Company Value
- shareholders' equity book value data:
Accounting Value of a Share Cytokinetics|CYTK - Company Book Value|Market-to-Book Ratio cytokinetics.com|CYTK - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Cytokinetics|CYTK - Long-Term Debt to Equity|Current Liabilities to Capital Cytokinetics|CYTK - Company Aggregate Debts|Debt to Net Assets Cytokinetics|CYTK - Company Long-Term Liabilities|Short-Term Debt Cytokinetics|Quick Liquidity Indicator cytokinetics.com
- financial results and valuation multiples details:
CYTK - Net Income|Expected Net Profit Cytokinetics|CYTK - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Cytokinetics Corp|CYTK - Price/Earnings to Growth Ratio|Company Value to EBITDA Cytokinetics Corp|CYTK - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Cytokinetics|CYTK - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months cytokinetics.com|CYTK - Earnings per share growth in current year|Projected earnings per share growth rate for next year Cytokinetics
- revenue and sales details:
CYTK - Revenue and Sales Volume|Company Expected Sales Volume Cytokinetics Inc|CYTK - Market Cap to Revenue|Price to Expected Revenue Ratio Cytokinetics Inc
Fundamental company valuation:CYTK Cytokinetics Inc
Flagship merchandise of Cytokinetics, Incorporated

This indicator measures the annual change in net income per share over the last twelve months, allowing for an assessment of the scaling pace of the business's actual earnings. By analyzing the percentage dynamics of EPS YoY TTM, an investor compares financial efficiency against the expenditures of Cytokinetics (CYTK) on AI-driven automation for drug synthesis and costly clinical trials supervised by cardiologists.

Direct competitors

Net earnings per one share for the last twelve months Jazz Pharma|PTCT (PTC Therapeutics Inc) - Net earnings per share for the last 12 months|Scholar Rock Inc. (SRRK) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Centessa Pharmaceuticals|Net earnings per one share for the last twelve months dyne-tx.com DYN|Earnings per share for the last twelve months Edgewise Corp (EWTX)|RAPP - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Alumis Corp ALMS|Zevra Corp - Earnings per share for the last twelve months|CTNM - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Larimar Therapeutics|CAPR: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Entrada TRDA|Net earnings per share for the last 12 months PTHS|Net earnings per one share for the last twelve months medicinova.com MNOV|Net earnings per share (EPS TTM) SER|Earnings per share for the last twelve months BTAI (BioXcel Therapeutics)|Earnings per share for the last twelve months ProMIS Neurosciences, Inc. PMN|APUS (Apimeds) - Earnings per one share for the last 12 months|AEON - Earnings per share for the last twelve months|Net earnings per share for the last four quarters NLS Pharmaceutics Ltd. NLSP|Bionomics Limited (BNOX) - Earnings per share for the last twelve months|fsdpharma.com - Earnings per share for the trailing year|RETA (reatapharma.com) - Net earnings per share (EPS TTM)